Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA project

Combination etanercept and methotrexate provides better disease control in very early (≤4 months) versus early rheumatoid arthritis (>4 months and

(2012) Paul Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial

(2012) Ronald F van Vollenhoven et al.   LANCET

Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study

(2012) Tuulikki Sokka et al.   ARTHRITIS RESEARCH & THERAPY

How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?

(2011) M. Neovius et al.   ANNALS OF THE RHEUMATIC DISEASES

A Comparison Between IgG- and IgA-class Antibodies to Cyclic Citrullinated Peptides and to Modified Citrullinated Vimentin in Early Rheumatoid Arthritis and Very Early Arthritis

(2011) A. SVARD et al.   JOURNAL OF RHEUMATOLOGY

The incidence of permanent work disability in patients with rheumatoid arthritis in Sweden 1990-2010: before and after introduction of biologic agents

(2011) E. Hallert et al.   RHEUMATOLOGY

(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis

(2011) Debby den Uyl et al.   ARTHRITIS RESEARCH & THERAPY

Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts

(2011) Sandeep K Agarwal et al.   ARTHRITIS RESEARCH & THERAPY

Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study

(2010) T. Olofsson et al.   ANNALS OF THE RHEUMATIC DISEASES

The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study

(2010) Frederick Wolfe et al.   ARTHRITIS RESEARCH & THERAPY

Rapid and sustained health utility gain in anti-tumour necrosis factor-treated inflammatory arthritis: observational data during 7 years in southern Sweden

(2009) A Gulfe et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis

(2008) Victoria Bejarano et al.   ARTHRITIS AND RHEUMATISM

Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: The jury is still out

(2008) Saralynn Allaire et al.   ARTHRITIS AND RHEUMATISM